MedicalResearch.com Interview with:
Maite Sabalza Ph.D
Post Doctoral Associate
Department of Basic Science and Craniofacial Biology
College of Dentistry, New York University
New York, NY 10010
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: With previous NIH funding we were able to develop an automated “dual assay” (able to detect both host antibodies and viral RNA) for HIV.
In relatively short time, we were able to migrate those findings into the new assay for ZIKA Virus.
MedicalResearch.com: What should readers take away from your report?
Response: Saliva is a good choice for diagnostics because it is a viable and noninvasive clinical matrix to detect both the presence of the infectious agent, and evidence of prior exposure (i.e., antibodies).
MedicalResearch.com: What recommendations do you have for future research as a result of this work?
Response: We believe that a dual assay for the presence of both ZIKV RNA and host antibodies provides a timeline of the stage of the infection.
MedicalResearch.com: Is there anything else you would like to add?
Response: We have developed a protocol that can be adapted for the next emerging infection.
Maite Sabalza ,Rubina Yasmin,Cheryl A. Barber,Talita Castro,Daniel Malamud,Beum Jun Kim,Hui Zhu,Richard A. Montagna,William R. Abrams
Published: February 5, 2018
The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.